| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 25.035 | 0 | 0 | 363 | 0 | 0 | 1.632 | 10.987 | 10.950 | 21.097 |
| Total Income - EUR | 25.035 | 0 | 4.947 | 363 | 0 | 0 | 1.632 | 10.987 | 14.941 | 27.380 |
| Total Expenses - EUR | 22.362 | 5.833 | 4.590 | 1.250 | 3.102 | 1.718 | 5.619 | 10.358 | 12.580 | 21.392 |
| Gross Profit/Loss - EUR | 2.674 | -5.833 | 357 | -887 | -3.102 | -1.718 | -3.986 | 628 | 2.360 | 5.988 |
| Net Profit/Loss - EUR | 1.922 | -5.833 | 208 | -898 | -3.102 | -1.718 | -4.035 | 299 | 1.973 | 4.981 |
| Employees | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Luanda Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 58 | 17 | 0 | 0 | 0 | 0 | 5.281 | 4.124 | 3.721 | 5.321 |
| Current Assets | 8.157 | 978 | 979 | 1.109 | 1.550 | 1.816 | 1.734 | 1.294 | 1.817 | 7.497 |
| Inventories | 4.503 | 0 | 0 | 0 | 0 | 0 | 0 | 406 | 0 | 0 |
| Receivables | 958 | 953 | 944 | 1.034 | 1.530 | 1.813 | 1.605 | 825 | 77 | 1.289 |
| Cash | 2.696 | 25 | 35 | 75 | 20 | 2 | 129 | 63 | 1.740 | 6.208 |
| Shareholders Funds | 2.795 | -3.067 | -2.807 | -3.653 | -6.685 | -8.275 | -12.127 | -11.866 | -9.857 | -4.821 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 5.420 | 4.062 | 3.786 | 4.762 | 8.234 | 10.091 | 19.142 | 17.284 | 15.395 | 17.639 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4619 - 4619" | |||||||||
| CAEN Financial Year |
4619
|
|||||||||
Comments - Luanda Med Srl